Munafa Stock Market Course + Intraday & FNO calls 
AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
AUROPHARMA NEWS reasons for why stock price of Aurobindo Pharma Limited is falling or rising
AUROPHARMA Aurobindo Pharma is falling or rising technical reasons
Technical analysis forecast for Aurobindo Pharma Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Aurobindo Pharma AUROPHARMA at this time. Stock is falling and might fall more.
It appears as if Aurobindo Pharma AUROPHARMA gave a large move recently.
Stock of Aurobindo Pharma (AUROPHARMA) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Aurobindo Pharma is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Aurobindo Pharma stays below 1146.5, but if it comes above 1146.5, then a intra day buy could be more profitable.
If you take a sell trade below 1146.5, then use 1146.5 as stoploss and 1110.3 as target. However if you take a buy trade in Aurobindo Pharma, then use 1146.5 as stoploss and 1176.71 as target.
AUROPHARMA Aurobindo Pharma is falling or rising NEWS fundamental reasons
Board Meeting to discuss Outcome of Board Meeting AUROPHARMA - NEWS as on 2026-02-10
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Investor Presentation - NEWS as on 2026-02-10
Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ?910 crore Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the O - NEWS as on 2026-02-09 business-standard.com
Company Announcement Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit III of Eugia Pharma Specialities Ltd., a wholly owned subsidiary company - NEWS as on 2026-02-09
Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9 Q3FY26 company results: Firms including GlaxoSmithKline Pharmaceuticals, The Ramco Cements, Linde India, Gulf Oil Lubricants, and Bata India are also to release their October-December earnings today - NEWS as on 2026-02-09 business-standard.com
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-02-05
More announcements and NEWS
AUROPHARMA Aurobindo Pharma Limited current price & indicator signals
Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Tue Feb 2026 | 1124.10 | 1106.00 to 1218.70 | -6.61% | 4.73 times |
| 09 Mon Feb 2026 | 1203.70 | 1171.50 to 1210.00 | 1.07% | 0.61 times |
| 06 Fri Feb 2026 | 1191.00 | 1166.00 to 1195.90 | 0.8% | 0.44 times |
| 05 Thu Feb 2026 | 1181.60 | 1176.90 to 1212.70 | -2.56% | 0.67 times |
| 04 Wed Feb 2026 | 1212.70 | 1166.00 to 1237.40 | -1.09% | 0.75 times |
| 03 Tue Feb 2026 | 1226.10 | 1211.20 to 1247.30 | 4.71% | 1.56 times |
| 02 Mon Feb 2026 | 1171.00 | 1152.30 to 1185.00 | -0.09% | 0.42 times |
| 01 Sun Feb 2026 | 1172.10 | 1163.10 to 1209.10 | -2.95% | 0.41 times |
| 30 Fri Jan 2026 | 1207.70 | 1174.00 to 1219.00 | 4.96% | 4.48 times |
| 29 Thu Jan 2026 | 1150.60 | 1127.20 to 1154.10 | 0.94% | 0.32 times |
| 28 Wed Jan 2026 | 1139.90 | 1122.20 to 1143.00 | 0.9% | 0.34 times |
| 27 Tue Jan 2026 | 1129.70 | 1116.20 to 1139.80 | -0.25% | 0.36 times |
Videos related to: AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
